Title:
APO-Bレベル低下のためのオメガ-3脂肪酸および脂質異常症剤
Document Type and Number:
Japanese Patent JP2010505956
Kind Code:
A
Abstract:
Methods of utilizing a combined administration or a unit dosage of a combination of a dyslipidemic agent and omega-3 fatty acids for the reduction of apolipoprotein-B levels. The methods are especially useful in the treatment of patients with hypercholesterolemia, hypertriglyceridemia, mixed dyslipidemia, coronary heart disease (CHD), vascular disease, atherosclerotic disease and related conditions, and for the prevention or reduction of cardiovascular, cardiac, and vascular events.
Inventors:
Rulov M. El Longhen
Robert A. Scharwitz
Douglas Kling
Ralph T. Doyle Jr.
Robert A. Scharwitz
Douglas Kling
Ralph T. Doyle Jr.
Application Number:
JP2009532391A
Publication Date:
February 25, 2010
Filing Date:
October 10, 2007
Export Citation:
Assignee:
RELIANT PHARMACEUTICALS, INC.
International Classes:
A61K31/202; A61K31/232; A61K45/00; A61P3/06; A61P9/10; A61P43/00
Attorney, Agent or Firm:
Mitsuo Tanaka
Hiroshi Yamazaki
Tadayuki Motoyama
Kenji Tomita
Nishino Mitsuru
Mizuhara Masahiro
Hiroshi Yamazaki
Tadayuki Motoyama
Kenji Tomita
Nishino Mitsuru
Mizuhara Masahiro